Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_assertion type Assertion NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_head.
- NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_assertion description "[Using real-time quantitative PCR (RT-qPCR) we found that CHL1 expression was decreased in 61% of breast, 60% of lung, 87% of clear cell and 89% papillary renal cancer specimens (P<0.03 for all the cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_provenance.
- NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_assertion evidence source_evidence_literature NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_provenance.
- NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_assertion SIO_000772 21408220 NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_provenance.
- NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_assertion wasDerivedFrom befree-20140225 NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_provenance.
- NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_assertion wasGeneratedBy ECO_0000203 NP909411.RAnPG6r8iEj2GfJ5xWkrtxVZ-aorvJTUjzxGBTX52iS8M130_provenance.